CCRN CROSS COUNTRY HEALTHCARE INC revenue, earnings and financials

For the quarter ended March 31, 2026, CROSS COUNTRY HEALTHCARE INC reported revenue of $241M (down 17.8% from a year earlier), net income of −$4.27M and diluted EPS of −$0.14; over the last four quarters revenue was $1.00B and net income −$98.6M; for the fiscal year ended December 2025 revenue was $1.05B, down 21.6% on the year before.

CCRN annual revenue and earnings

• Fiscal year ended Dec 2025: revenue $1.05B, gross profit n/a, operating income −$84.4M, net income −$94.9M (margin -9.0%), EPS −$2.93
• Fiscal year ended Dec 2024: revenue $1.34B, gross profit n/a, operating income −$16.9M, net income −$14.6M (margin -1.1%), EPS −$0.44
• Fiscal year ended Dec 2023: revenue $2.02B, gross profit n/a, operating income $113M, net income $72.6M (margin 3.6%), EPS $2.05
• Fiscal year ended Dec 2022: revenue $2.80B, gross profit n/a, operating income $270M, net income $188M (margin 6.7%), EPS $4.95
• Fiscal year ended Dec 2021: revenue $1.68B, gross profit n/a, operating income $139M, net income $132M (margin 7.9%), EPS $3.53

CCRN quarterly revenue and earnings

• Quarter ended Mar 31, 2026: revenue $241M (down 17.8% year over year), net income −$4.27M, EPS −$0.14
• Quarter ended Dec 31, 2025: revenue $237M (down 23.6% year over year), net income −$82.9M, EPS −$2.56
• Quarter ended Sep 30, 2025: revenue $250M (down 20.6% year over year), net income −$4.77M, EPS −$0.15
• Quarter ended Jun 30, 2025: revenue $274M (down 19.3% year over year), net income −$6.66M, EPS −$0.20
• Quarter ended Mar 31, 2025: revenue $293M (down 22.6% year over year), net income −$490K, EPS −$0.02
• Quarter ended Dec 31, 2024: revenue $310M (down 25.1% year over year), net income −$3.75M, EPS −$0.12
• Quarter ended Sep 30, 2024: revenue $315M (down 28.8% year over year), net income $2.56M, EPS $0.08
• Quarter ended Jun 30, 2024: revenue $340M (down 37.2% year over year), net income −$16.1M, EPS −$0.47
• Quarter ended Mar 31, 2024: revenue $379M (down 39.1% year over year), net income $2.69M, EPS $0.08
• Quarter ended Dec 31, 2023: revenue $414M (down 34.1% year over year), net income $9.04M, EPS $0.26
• Quarter ended Sep 30, 2023: revenue $442M (down 30.5% year over year), net income $12.8M, EPS $0.36
• Quarter ended Jun 30, 2023: revenue $541M (down 28.2% year over year), net income $21.3M, EPS $0.60
• Quarter ended Mar 31, 2023: revenue $623M (down 21.0% year over year), net income $29.4M, EPS $0.81
• Quarter ended Dec 31, 2022: revenue $628M (down 1.9% year over year), net income $38.8M, EPS $1.05
• Quarter ended Sep 30, 2022: revenue $636M (up 69.7% year over year), net income $34.8M, EPS $0.93
• Quarter ended Jun 30, 2022: revenue $754M (up 127.1% year over year), net income $52.9M, EPS $1.40
• Quarter ended Mar 31, 2022: revenue $789M (up 139.6% year over year), net income $62.0M, EPS $1.63
• Quarter ended Dec 31, 2021: revenue $641M, net income $77.6M, EPS $2.07
• Quarter ended Sep 30, 2021: revenue $375M, net income $23.4M, EPS $0.62
• Quarter ended Jun 30, 2021: revenue $332M, net income $11.5M, EPS $0.31

CCRN cash flow, buybacks and dividends

• Fiscal year ended Dec 2025: operating cash flow $48.3M, share buybacks $6.83M
• Fiscal year ended Dec 2024: operating cash flow $120M, share buybacks $37.3M
• Fiscal year ended Dec 2023: operating cash flow $248M, share buybacks $57.7M
• Fiscal year ended Dec 2022: operating cash flow $134M, share buybacks $35.3M
• Fiscal year ended Dec 2021: operating cash flow −$85.6M, share buybacks $0

CCRN balance sheet

• Mar 31, 2026: cash $106M, total assets $451M, total liabilities $138M, shareholders' equity $313M
• Dec 31, 2025: cash $109M, total assets $449M, total liabilities $126M, shareholders' equity $323M
• Sep 30, 2025: cash $99.1M, total assets $538M, total liabilities $130M, shareholders' equity $408M
• Jun 30, 2025: cash $81.2M, total assets $554M, total liabilities $142M, shareholders' equity $412M
• Mar 31, 2025: cash $80.7M, total assets $576M, total liabilities $158M, shareholders' equity $418M
• Dec 31, 2024: cash $81.6M, total assets $589M, total liabilities $170M, shareholders' equity $419M
• Sep 30, 2024: cash $64.0M, total assets $597M, total liabilities $173M, shareholders' equity $425M
• Jun 30, 2024: cash $69.6M, total assets $603M, total liabilities $164M, shareholders' equity $433M

What is CCRN's revenue?

CROSS COUNTRY HEALTHCARE INC reported $1.00B of revenue over its last four quarters, through March 31, 2026.

Is CCRN profitable?

No. CROSS COUNTRY HEALTHCARE INC lost $98.6M over the last four quarters.

What is CCRN's EPS?

Diluted earnings per share over the last four quarters were −$3.05; −$0.14 in the latest quarter.

CCRN ownership and insider trades · All stocks